ARCUTIS BIOTHERAPEUTICS, INC. Shares Outstanding (Cover Page)
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) had Shares Outstanding (Cover Page) of 125.69 million shares as of 2026-07-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-31: Entity Common Stock, Shares Outstanding 125.69M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 125.08M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 124.03M shares.
- 2025-10-22: Entity Common Stock, Shares Outstanding 122.49M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 125.69M shares 10-Q · filed 2026-08-05 |
| 2026-04-30 | 125.08M shares 10-Q · filed 2026-05-06 |
| 2026-02-20 | 124.03M shares 10-K · filed 2026-02-25 |
| 2025-10-22 | 122.49M shares 10-Q · filed 2025-10-28 |
| 2025-07-31 | 119.91M shares 10-Q · filed 2025-08-06 |
| 2025-05-01 | 119.20M shares 10-Q · filed 2025-05-06 |
| 2025-02-19 | 118.64M shares 10-K · filed 2025-02-25 |
| 2024-11-01 | 117.04M shares 10-Q · filed 2024-11-06 |
| 2024-08-09 | 116.89M shares 10-Q · filed 2024-08-14 |
| 2024-05-10 | 115.76M shares 10-Q/A · filed 2024-07-24 |
| 2024-02-21 | 96.81M shares 10-K · filed 2024-02-27 |
| 2023-10-31 | 94.38M shares 10-Q · filed 2023-11-03 |
| 2023-08-04 | 61.65M shares 10-Q/A · filed 2023-09-15 |
| 2023-05-04 | 61.42M shares 10-Q/A · filed 2023-09-15 |
| 2023-02-24 | 61.08M shares 10-K/A · filed 2023-09-15 |
| 2022-11-04 | 60.93M shares 10-Q · filed 2022-11-08 |
| 2022-07-29 | 51.56M shares 10-Q · filed 2022-08-04 |
| 2022-04-29 | 51.42M shares 10-Q · filed 2022-05-05 |
| 2022-02-16 | 50.38M shares 10-K/A · filed 2022-03-03 |
| 2021-10-29 | 50.30M shares 10-Q · filed 2021-11-04 |
| 2021-07-30 | 50.24M shares 10-Q · filed 2021-08-05 |
| 2021-04-30 | 50.21M shares 10-Q · filed 2021-05-06 |
| 2021-02-11 | 50.08M shares 10-K · filed 2021-02-16 |
| 2020-10-31 | 43.63M shares 10-Q · filed 2020-11-05 |
| 2020-08-01 | 38.19M shares 10-Q · filed 2020-08-11 |
| 2020-05-01 | 38.15M shares 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |